PALUMED S.A. is a pharmaceutical company developing novel antimalarial drugs candidates against resistant strains of Plasmodium falciparum.
palumed, médicament antipaludique, médicament antipaludéen, antimalarial drug, dérivés de l'artémisinine, artemisinin derivatives, palumed, trioxaquine, pharmaceutical development company, société de développement pharmaceutique, plasmodium falciparum, resistant strain, souche résistante, artemether, aminoquinoline, chimioresistance, chemoresistance, chloroquine, quinoleine, quinoline, trioxane, neuropaludisme, cerebral malaria, severe malaria, bitherapy, bithérapie, heme, haem, hemozoïne, hemozoin, haemozoin, polychimiothérapie, polychemotherapy